Oncoinvent ASA

kr 62.60As of Sun 8 Nov 2026, 12:00 UTC
OSL:ONCINHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (228.06%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (17.91%)
Mkt cap kr 383.6M
ROIC (138.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 70
11.32%
(73.08%)
Hold 9|8|12|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.69
0.70
0.74
0.74
(9.99%)
(5.42%)
2.41%
3.04%
Revenuekr M
19.68
19.90
21.08
21.79
8.47%
4.53%
6.19%
11.96%
Peers (US$40.58M)
Cap (US$)
PE
52.12M
—
40.84M
—
Capital
TTM
5Y
10Y
Leveragex
0.742
0.112
0.070
EBIT/Intx
0.782
1.232
1.153
Own earn%
51.10
(29.47)
(27.72)
Sh yield%
36.01
28.57
27.60
Owners
Insiders/Inst%
8.37
65.23
Short interest%
2.13
SBC / revenue%
4.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
16